|

High Resolution Diffusion Weighted Imaging in Prostate

RECRUITINGSponsored by The First Affiliated Hospital with Nanjing Medical University
Actively Recruiting
SponsorThe First Affiliated Hospital with Nanjing Medical University
Started2023-08-01
Est. completion2025-07-31
Eligibility
Age55 Years+
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06636747

Summary

hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI

Eligibility

Age: 55 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

1. Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps;
2. Complete clinical information.

Exclusion Criteria:

Men were excluded if they were using 5-alpha-reductase inhibitors at time of examination or has used such during the previous six months; or if they had a previous history of prostatic biopsy, prostatic surgery, or treatment for PCa

Conditions3

CancerProstate CancerProstate Disease

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.